UPDATE ON VACCINE IN INDIA AND WORLD
Covaxin approved for emergency use for children between 2-18 years.
Tag: Covaxin
Covid Vaccination Progress In India
India began administration of COVID-19 vaccines on 16 January 2021. As of 13 September 2021, India has administered over 752 ...
Zydus Cadila’s New ZyCoV-D Can Help !
India's second vaccine, Zydus Cadila's new ZyCoV-D, based in Ahmedabad, has acquired ready permissions from the authorities to begin phase ...
Are vaccines enough?
The tsunami of the pandemic has already wiped out a prominent part of the population and who knows how worse ...
Bharat Biotech’s Covaxin gets approval for Phase 2, 3 trials for 2-18-year-olds
THD NewsDesk, New Delhi: Bharat Biotech's Covid-19 vaccine "Covaxin" has been approved for the phase II/III clinical trial on those aged ...
Maharashtra state-owned Haffkine Bio-Pharmaceutical Corporation Limited to produce Covaxin; Project to cost 154 crores
THD NewsDesk, Maharashtra: The Central government gave assent to Haffkine Bio-Pharmaceutical Corporation Limited to produce Covaxin, a Covid-19 vaccine developed by ...
Infosys, Accenture to cover Covid-19 vaccination costs for Indian employees and immediate family
THD NewsDesk, New Delhi: On Wednesday, Information Technology major Infosys Ltd and consulting and outsourcing services provider Accenture PLC, Bengaluru ...
Covid vaccine beneficiaries may not have the option of choosing between Covaxin and Covishield
Both Covishield and Covaxin are being locally manufactured at SII and Bharat Biotech, respectively. Drug regulators and health secretary have ...
Masks may never even go, says ICMR chief Balram Bhargava
THD NewsDesk, New Delhi: Moments following two vaccines were passed under contained use, and emergency use authorization by Directorate General of ...
Venkaiah Naidu meets Bharat Biotech CMD to discusses the status of Covaxin
The discussion orbited encompassing the state of the indigenous vaccine, Covaxin, and the strategies to make it ready in India ...
